Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA Regimens in Total Knee Arthroplasty
NCT04443920Phase 4Completed
- Sponsor
- The Miriam Hospital
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Tranexamic acid (TXA) with Placebo Normal Saline (NS) (2 arms). Primary endpoint: Assessment of changes in hemostasis via viscoelastic testing. Started Oct 2019; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04443920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443920.